Optinose, inc. (OPTN)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Dec'16
Assets
Current assets:
Cash and cash equivalents

148,475

147,144

125,490

143,963

171,316

200,990

221,491

244,990

209,771

234,854

49,410

36,797

Accounts receivable, net

11,733

13,643

10,746

9,311

5,793

2,310

2,923

3,671

2,049

0

-

-

Grants and other receivables

-

-

-

-

-

242

-

-

-

-

-

-

Grants and other receivables

-

-

232

290

124

-

182

211

271

46

231

384

Inventory

5,709

3,484

4,404

4,260

5,716

7,132

7,009

4,950

3,580

2,013

241

0

Prepaid expenses and other current assets

3,760

3,789

3,230

3,030

3,833

-

1,850

2,232

1,398

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

2,183

-

-

-

1,254

438

3,494

Total current assets

169,677

168,060

144,102

160,854

186,782

212,857

233,455

256,054

217,069

238,167

50,320

40,675

Property and equipment, net

2,980

3,052

3,261

3,531

3,715

3,884

3,957

3,596

3,102

2,564

1,433

323

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

2,285

-

Other assets

1,513

1,538

2,014

2,187

2,495

248

210

300

391

405

1,097

553

Total assets

174,170

172,650

149,377

166,572

192,992

216,989

237,622

259,950

220,562

241,136

55,135

41,551

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

5,403

3,625

5,112

2,811

7,676

7,116

6,549

6,951

7,996

5,893

3,876

3,369

Accrued expenses and other current liabilities

28,822

32,514

24,850

21,556

19,192

18,421

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

15,645

16,254

14,492

8,698

5,606

2,541

Deferred other income

-

-

0

0

0

160

168

8

-

186

-

-

Deferred other income

-

-

-

-

-

-

-

-

0

-

217

0

Total current liabilities

34,225

36,139

29,962

24,367

26,868

25,697

22,362

23,213

22,488

14,777

9,699

5,910

Convertible notes payable, net

-

-

-

-

-

-

-

-

-

-

0

15,256

Long-term debt, net

-

-

-

-

-

72,500

-

-

-

71,863

-

0

Long-term debt, net

104,656

74,531

74,266

72,869

72,680

-

72,318

72,138

71,963

-

-

-

Other liabilities

158

397

631

864

1,091

181

212

267

-

0

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

0

3,409

Total liabilities

139,039

111,067

104,859

98,100

100,639

98,378

94,892

95,618

94,451

86,640

9,699

24,575

Commitments and contingencies (Note 11)

-

-

-

-

-

-

-

-

-

-

-

0

Redeemable shares, carrying amount

-

-

-

-

-

-

-

-

-

-

236,542

168,173

Stockholders' equity:
Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019; 45,906,162 shares issued and outstanding at March 31, 2020 and December 31, 2019

46

46

41

41

41

41

41

41

38

38

4

4

Additional paid-in capital

491,994

489,565

447,541

442,676

439,167

436,554

434,312

430,803

368,018

365,838

0

0

Accumulated deficit

-456,836

-427,980

-402,985

-374,178

-346,801

-317,927

-291,546

-266,423

-241,841

-211,269

-191,001

-151,102

Accumulated other comprehensive loss

-73

-48

-79

-67

-54

-57

-77

-89

-104

-111

-109

-99

Total stockholders' equity

35,131

61,583

44,518

68,472

92,353

118,611

142,730

164,332

126,111

154,496

-191,106

-151,197

Total liabilities and stockholders' equity

174,170

172,650

149,377

166,572

192,992

216,989

237,622

259,950

220,562

241,136

55,135

41,551